AbbVie Inc. (ABBV34.SA)
São Paulo - São Paulo Delayed price. Currency in BRL
Add to watchlist
At close: 04:12PM BRT
| Previous close | 58.56 |
| Open | 0.00 |
| Bid | 57.96 x 0 |
| Ask | 58.74 x 0 |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 2,167 |
| Market cap | 1.641T |
| Beta (5Y monthly) | 0.58 |
| PE ratio (TTM) | 51.40 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.46 (2.51%) |
| Ex-dividend date | 12 Apr 2024 |
| 1y target est | N/A |
- PR Newswire
AbbVie Provides U.S. Regulatory Update on ABBV-951 (Foscarbidopa/Foslevodopa)
AbbVie (NYSE: ABBV) today announced it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) for the New Drug Application (NDA) for ABBV-951 (foscarbidopa/foslevodopa) for the treatment of motor fluctuations in adults with advanced Parkinson's disease.
- PR Newswire
AbbVie Declares Quarterly Dividend
The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.55 per share.
- PR Newswire
AbbVie Appoints Roxanne S. Austin as Lead Independent Director of the Board of Directors
AbbVie (NYSE: ABBV) today announced that the independent directors of the board have selected Roxanne S. Austin as lead independent director, effective July 1, 2024. Ms. Austin succeeds Glenn F. Tilton, who has served as lead independent director since 2013. Mr. Tilton will continue to serve on the AbbVie Board as an independent director.
© 2024 Yahoo. All rights reserved.